Meinl Lab
Human Neuroimmunology
© J. Greune / LMU
Prof. Dr. Edgar Meinl
Human Neuroimmunology
Institute of Clinical Neuroimmunology
+49 89 2180 71665
edgar.meinl@med.uni-muenchen.de
Research Topics
- Autoimmunity to known and novel targets in the CNS
- B cells and B cell directed therapies in CNS inflammation
- Immune response to SARS-CoV-2
In Multiple sclerosis (MS) and related diseases misguided autoreactive immune cells attack the own central nervous system (CNS) and induce chronic inflammation. We aim to (1) explore the autoimmunity against known target antigens and identify novel targets to stratify patients, (2) study B cells and B cell directed therapies in MS and related diseases, and (3) apply our experiences in human immunology to understand long-term protection against SARS-CoV-2 focusing on the development and maintenance of memory B cells. Read more...
Publications
Scientific vita
- since 2003
- Professor, Institute of Clinical Neuroimmunology, University Hospital and Biomedical Center, LMU Munich
- 1999-2003
- Group leader, Institute of Clinical Neuroimmunology, University Hospital and Biomedical Center, LMU Munich
- 1994-1999
- Group leader, Institute of Clinical und Molecular Virology, Friedrich-Alexander-Universität Erlangen-Nürnberg
- 1990-1994
- Postdoctoral researcher, Department of Neuroimmunology, Max Planck Institute of Psychiatry, Martinsried
- 1988-1989
- Postgraduate and Medical Degree, Clinical Research Unit for Multiple Sclerosis of the Max Planck Society in Würzburg